Targeting Brain Cancer Cell Metabolism May Provide New Treatment, University of California, Los Angeles (UCLA) Study

Bookmark and Share

UCLA -- Inhibiting fatty acid synthesis in brain cancer cells may offer a new option for treating the 50 percent of deadly glioblastomas that are driven by amplified signaling of the epidermal growth factor receptor (EFGR), according to a first-of-its-kind study by researchers at UCLA's Jonsson Comprehensive Cancer Center.

Back to news